Effects of cannabidiol (CBD) treatment on age-related cognitive decline in C57 mice
Abstract Aging is associated with cognitive decline, and currently, there are no approved medications that can prevent these impairments. Recently,…
acetylcholine
Boosting Acetylcholine Signaling by Cannabidiol in a Murine Model of Alzheimer’s Disease
Abstract Alzheimer’s disease (AD) is a challenging medical issue that requires efficacious treatment options to improve long-term quality of life.…
Cannabinoids and Multiple Sclerosis: A Critical Analysis of Therapeutic Potentials and Safety Concerns
Abstract Multiple sclerosis (MS) is a complicated condition in which the immune system attacks myelinated axons in the central nervous…
Prolonged efavirenz exposure reduces peripheral oxytocin and vasopressin comparable to known drugs of addiction in male Sprague Dawley rats
Abstract Introduction: Several drugs of abuse (DOA) are capable of modulating neurohypophysial hormones, such as oxytocin (OT) and vasopressin (VP),…
Hemobilia after laparoscopic cholecystectomy that was successfully treated conservatively: Case report
Abstract Hemobilia from pseudoaneurysm rupture after laparoscopic cholecystectomy is rare. Due to consequent rapid hemodynamic instability, it could be life…
Crosstalk between the M1 muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer’s disease?
Abstract Alzheimer’s disease (AD) is a neurodegenerative disorder which accounts for 60–70% of the 50 million worldwide cases of dementia…